NCT06690632Recruiting
WAter Preparation in Crohn's Disease's Imagery
WAter Preparation for Magnetic Resonance Enterography in Crohn's Disease
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to compare distension quality and patient experience of water and polyethylene glycol preparation as oral contrast media in Magnetic Resonance Enterography (MRE) in patients with Crohn's disease. Thus, the main question it aims to answer is: Is water sufficient to interpret MRE from patients with Crohn's disease? Researchers will compare the standard protocol (polyethylene glycol) with water as bowel distension agent to see if it is possible to obtain a satisfying global distension of small bowel. Participants will undergo the same procedures as standard care adding questionnaires and replacing water as the bowel distension agent for the MRE for patient randomized into the experimental group.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 194 (estimated)
- First submitted
- 29 Oct 2024
- Start date
- 29 Jan 2025
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Crohn's disease
- NCT number
- NCT06690632
What you commit to
- Study type: Interventional
- Planned participants: 194
- From 29 Jan 2025 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patient under guardianship or curatorship, allergy to PEG,
- contraindication to gadolinium administration (kidney failure with glomerular filtration rate \< 30/mL/1.73m², pregnancy, allergy).
Age
- \< 18 years old,
Other
- inability to obtain an informed consent,
- contraindication to MRE (pregnancy, pace maker, claustrophobia in particular), - contraindication to phloroglucinol administration (phenylcetonuria),
Who the study is looking for
- Diagnosis of Crohn's Disease,
- need for MRE (determined by patient's gastroenterologist)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Toulouse Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.